Agilent Technologies EBITDA 2010-2025 | A

Agilent Technologies annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Agilent Technologies EBITDA for the quarter ending January 31, 2025 was $448M, a 0.45% increase year-over-year.
  • Agilent Technologies EBITDA for the twelve months ending January 31, 2025 was $1.747B, a 10.99% increase year-over-year.
  • Agilent Technologies 2024 annual EBITDA was $1.745B, a 7.65% increase from 2023.
  • Agilent Technologies 2023 annual EBITDA was $1.621B, a 16.23% decline from 2022.
  • Agilent Technologies 2022 annual EBITDA was $1.935B, a 16.01% increase from 2021.
Agilent Technologies Annual EBITDA
(Millions of US $)
2024 $1,745
2023 $1,621
2022 $1,935
2021 $1,668
2020 $1,154
2019 $1,179
2018 $1,114
2017 $1,019
2016 $861
2015 $775
2014 $781
2013 $758
2012 $1,420
2011 $1,324
2010 $768
2009 $209
Agilent Technologies Quarterly EBITDA
(Millions of US $)
2025-01-31 $448
2024-10-31 $477
2024-07-31 $396
2024-04-30 $426
2024-01-31 $446
2023-10-31 $470
2023-07-31 $204
2023-04-30 $454
2023-01-31 $493
2022-10-31 $544
2022-07-31 $491
2022-04-30 $442
2022-01-31 $458
2021-10-31 $479
2021-07-31 $420
2021-04-30 $365
2021-01-31 $404
2020-10-31 $375
2020-07-31 $307
2020-04-30 $178
2020-01-31 $294
2019-10-31 $326
2019-07-31 $280
2019-04-30 $269
2019-01-31 $304
2018-10-31 $300
2018-07-31 $274
2018-04-30 $260
2018-01-31 $280
2017-10-31 $251
2017-07-31 $252
2017-04-30 $255
2017-01-31 $261
2016-10-31 $239
2016-07-31 $206
2016-04-30 $195
2016-01-31 $221
2015-10-31 $216
2015-07-31 $206
2015-04-30 $170
2015-01-31 $183
2014-10-31 $253
2014-07-31 $221
2014-04-30 $191
2014-01-31 $220
2013-10-31 $380
2013-07-31 $327
2013-04-30 $305
2013-01-31 $311
2012-10-31 $372
2012-07-31 $354
2012-04-30 $361
2012-01-31 $333
2011-10-31 $376
2011-07-31 $344
2011-04-30 $330
2011-01-31 $274
2010-10-31 $270
2010-07-31 $175
2010-04-30 $190
2010-01-31 $133
2009-10-31 $111
2009-07-31 $40
2009-04-30 $-7
2009-01-31 $65
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $32.907B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $224.526B 27.00
Boston Scientific (BSX) United States $152.309B 38.13
Stryker (SYK) United States $147.916B 30.93
EssilorLuxottica (ESLOY) France $129.703B 0.00
Medtronic (MDT) Ireland $109.157B 15.94
Lonza Group Ag (LZAGY) Switzerland $49.583B 0.00
Haleon (HLN) United Kingdom $47.109B 26.80
ResMed (RMD) United States $36.312B 27.27
GE HealthCare Technologies (GEHC) United States $33.806B 16.05
Terumo (TRUMY) Japan $27.953B 0.00
Koninklijke Philips (PHG) Netherlands $22.765B 16.36
Insulet (PODD) United States $22.130B 86.87
Zimmer Biomet Holdings (ZBH) United States $19.288B 12.39
Baxter (BAX) United States $15.985B 11.94
Smith & Nephew SNATS (SNN) United Kingdom $12.381B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $7.091B 23.97
Lantheus Holdings (LNTH) United States $5.462B 13.78
Prestige Consumer Healthcare (PBH) United States $4.298B 19.20
Perrigo (PRGO) Ireland $3.605B 9.14
ICU Medical (ICUI) United States $3.534B 26.06
Haemonetics (HAE) United States $3.473B 15.13
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.154B 26.21
QuidelOrtho (QDEL) United States $2.401B 16.52
GN Store Nord (GNNDY) Denmark $2.164B 17.92
LeMaitre Vascular (LMAT) United States $1.882B 42.06
AtriCure (ATRC) United States $1.558B 0.00
Neogen (NEOG) United States $1.409B 18.03
AdaptHealth (AHCO) United States $1.217B 12.36
Kestra Medical Technologies (KMTS) United States $1.179B 0.00
Green Thumb Industries (GTBIF) United States $1.172B 26.35
BioLife Solutions (BLFS) United States $1.097B 0.00
InMode (INMD) Israel $1.038B 9.50
Phibro Animal Health (PAHC) United States $0.996B 12.75
Evolus (EOLS) United States $0.653B 0.00
CeriBell (CBLL) United States $0.600B 0.00
Curaleaf Holdings (CURLF) Canada $0.577B 0.00
Owens & Minor (OMI) United States $0.559B 4.63
Valneva SE (VALN) France $0.534B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.524B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Surmodics (SRDX) United States $0.398B 0.00
Cresco Labs (CRLBF) United States $0.350B 0.00
SNDL (SNDL) Canada $0.347B 0.00
Capricor Therapeutics (CAPR) United States $0.333B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Sanara MedTech (SMTI) United States $0.312B 0.00
VAREX IMAGING (VREX) United States $0.309B 11.36
Aurora Cannabis (ACB) Canada $0.290B 51.60
Sanuwave Health (SNWV) United States $0.285B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.97
Canopy Growth (CGC) Canada $0.267B 0.00
Omeros (OMER) United States $0.258B 0.00
Verano Holdings (VRNOF) United States $0.255B 0.00
Cerus (CERS) United States $0.250B 0.00
ZimVie (ZIMV) United States $0.248B 11.28
Biote (BTMD) United States $0.214B 6.02
OraSure Technologies (OSUR) United States $0.198B 0.00
High Tide (HITI) Canada $0.186B 0.00
Brainsway (BWAY) Israel $0.185B 49.05
Quanterix (QTRX) United States $0.180B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.47
Organigram Global (OGI) Canada $0.166B 0.00
TriSalus Life Sciences (TLSI) United States $0.164B 0.00
FitLife Brands (FTLF) United States $0.148B 18.19
Jin Medical (ZJYL) China $0.133B 0.00
Exagen (XGN) United States $0.120B 0.00
TerrAscend (TSNDF) Canada $0.116B 0.00
Agape ATP (ATPC) $0.101B 0.00
MacroGenics (MGNX) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Fonar (FONR) United States $0.077B 10.71
Veru (VERU) United States $0.076B 0.00
Quipt Home Medical (QIPT) United States $0.072B 0.00
InterCure (INCR) Israel $0.070B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
Zynex (ZYXI) United States $0.066B 0.00
United Health Products (UEEC) United States $0.061B 0.00
Apyx Medical (APYX) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.037B 12.94
Rockwell Medical (RMTI) United States $0.037B 0.00
Safety Shot (SHOT) United States $0.034B 0.00
Nephros (NEPH) United States $0.023B 0.00
INLIF (INLF) $0.020B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00